| 摘要 |
<p>A new pharmaceutical formulation comprising the thrombin inhibitor HOOC-CH2-(R)-Cgl-Aze-Pab in combination with medium chain glycerides, a process for the preparation of such a pharmaceutical formulation, the use of such formulation in the treatment of thromboembolism as well as a method of treating a patient in need of such a treatment by using said formulation.</p> |
